• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI 3激酶的p110β亚型而非p110α亚型的过表达会抑制乳腺癌细胞的运动能力。

Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.

作者信息

Yip Shu-Chin, El-Sibai Mirvat, Hill Karen M, Wu Haiyan, Fu Zheng, Condeelis John S, Backer Jonathan M

机构信息

Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

出版信息

Cell Motil Cytoskeleton. 2004 Nov;59(3):180-8. doi: 10.1002/cm.20032.

DOI:10.1002/cm.20032
PMID:15468162
Abstract

Phosphoinositide 3-kinase (PI 3-kinase) activity is required for growth factor-induced cytoskeletal regulation and cell migration. We previously found that in MTLn3 rat adenocarcinoma cells, EGF-stimulated induction of actin barbed ends and lamellipod extension specifically requires the p85/p110alpha isoform of PI 3-kinase. To further characterize signaling by distinct PI 3-kinase isoforms, we have developed MTLn3 cells that transiently or stably overexpress either p110alpha or p110beta. Transient overexpression of p110beta inhibited EGF-stimulated lamellipod extension, whereas p110alpha-transfected cells showed normal EGF-stimulated lamellipod extension. Similar results were obtained by overexpression of kinase-dead p110beta, suggesting that effects on cytoskeletal signaling were due to competition with p85/p110alpha complexes. Stable overexpression of p110alpha appeared to be toxic, based on the difficulty in obtaining stable overexpressing clones. In contrast, cells expressing a 2-fold increase in p110beta were readily obtainable. Interestingly, cells stably expressing p110beta showed a marked inhibition of EGF-stimulated lamellipod extension. Using computer-assisted analysis of time-lapse images, we found that overexpression of p110beta caused a nearly complete inhibition of motility. Cells overexpressing p110beta showed normal activation of Akt and Erk, suggesting that overall PI 3-kinase signaling was intact. A chimeric p110 molecule containing the p85-binding and Ras-binding domains of p110alpha and the C2, helical, and kinase domains of p110beta, was catalytically active yet also inhibited EGF-stimulated lamellipod extension. These data highlight the differential signaling by distinct p110 isoforms. Identification of effectors that are differently regulated by p110alpha versus p110beta will be important for understanding cell migration and its role in metastasis.

摘要

磷脂酰肌醇3激酶(PI 3激酶)活性是生长因子诱导的细胞骨架调节和细胞迁移所必需的。我们之前发现,在MTLn3大鼠腺癌细胞中,表皮生长因子(EGF)刺激诱导肌动蛋白丝的刺端和片状伪足延伸特别需要PI 3激酶的p85/p110α亚型。为了进一步表征不同PI 3激酶亚型的信号传导,我们构建了瞬时或稳定过表达p110α或p110β的MTLn3细胞。p110β的瞬时过表达抑制了EGF刺激的片状伪足延伸,而转染p110α的细胞显示出正常的EGF刺激的片状伪足延伸。通过过表达激酶失活的p110β也获得了类似的结果,这表明对细胞骨架信号传导的影响是由于与p85/p110α复合物的竞争。基于难以获得稳定过表达克隆,p110α的稳定过表达似乎具有毒性。相比之下,p110β表达增加两倍的细胞很容易获得。有趣的是,稳定表达p110β的细胞显示出EGF刺激的片状伪足延伸受到明显抑制。使用延时图像的计算机辅助分析,我们发现p110β的过表达导致运动性几乎完全受到抑制。过表达p110β的细胞显示Akt和Erk的正常激活,这表明整体PI 3激酶信号传导是完整的。一种嵌合p110分子,包含p110α的p85结合和Ras结合结构域以及p110β的C2、螺旋和激酶结构域,具有催化活性,但也抑制了EGF刺激的片状伪足延伸。这些数据突出了不同p110亚型的差异信号传导。鉴定受p110α与p110β不同调节的效应器对于理解细胞迁移及其在转移中的作用将是重要的。

相似文献

1
Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.PI 3激酶的p110β亚型而非p110α亚型的过表达会抑制乳腺癌细胞的运动能力。
Cell Motil Cytoskeleton. 2004 Nov;59(3):180-8. doi: 10.1002/cm.20032.
2
Specific requirement for the p85-p110alpha phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells.乳腺癌细胞中表皮生长因子刺激的肌动蛋白成核过程中p85-p110α磷脂酰肌醇3-激酶的特殊要求。
J Biol Chem. 2000 Feb 11;275(6):3741-4. doi: 10.1074/jbc.275.6.3741.
3
N-terminal domains of the class ia phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling.Ⅰa类磷酸肌醇3激酶调节亚基的N端结构域在细胞骨架信号传导中起作用,但在促有丝分裂信号传导中不起作用。
J Biol Chem. 2001 May 11;276(19):16374-8. doi: 10.1074/jbc.M006985200. Epub 2001 Feb 14.
4
The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGF-stimulated cell migration.在表皮生长因子(EGF)刺激的细胞迁移过程中,Ras和Rac在磷脂酰肌醇-3激酶(PI 3-激酶)依赖性突起形成中的不同作用。
J Cell Sci. 2007 Sep 1;120(Pt 17):3138-46. doi: 10.1242/jcs.005298. Epub 2007 Aug 14.
5
p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity.p110β在3T3-L1细胞分化过程中上调,并有助于产生高度胰岛素反应性的葡萄糖转运活性。
J Biol Chem. 2000 Jun 9;275(23):17671-6. doi: 10.1074/jbc.M910391199.
6
Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells.Cdc42是MTLn3癌细胞中表皮生长因子(EGF)刺激的细胞突起和运动所必需的。
J Cell Sci. 2007 Oct 1;120(Pt 19):3465-74. doi: 10.1242/jcs.005942. Epub 2007 Sep 12.
7
A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.PI3K p110β催化亚基致癌潜能的生化机制。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19897-902. doi: 10.1073/pnas.1008739107. Epub 2010 Oct 28.
8
Signaling via class IA Phosphoinositide 3-kinases (PI3K) in human, breast-derived cell lines.人类乳腺细胞系中 IA 类磷酯酰肌醇 3-激酶(PI3K)的信号转导
PLoS One. 2013 Oct 4;8(10):e75045. doi: 10.1371/journal.pone.0075045. eCollection 2013.
9
PI3-kinase p110α mediates β1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading.PI3-kinase p110α 介导 β1 整合素诱导的 Akt 活化和细胞黏附及初始铺展过程中的膜突出。
Cell Signal. 2010 Dec;22(12):1838-48. doi: 10.1016/j.cellsig.2010.07.011. Epub 2010 Jul 25.
10
The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.PI3K p110β 在人前列腺癌细胞中 AKT 信号、细胞存活和增殖中的作用。
Prostate. 2010 May 15;70(7):755-64. doi: 10.1002/pros.21108.

引用本文的文献

1
Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases - potentially novel therapeutic targets.磷脂酰肌醇 3-激酶调节亚基的同工型特异性活性——潜在的新型治疗靶点。
Expert Opin Ther Targets. 2018 Oct;22(10):869-877. doi: 10.1080/14728222.2018.1522302. Epub 2018 Sep 24.
2
PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.PI3K p110β亚型通过抑制Akt和FAK,在胶质母细胞瘤细胞增殖和迁移的调控中与JNK协同作用。
J Exp Clin Cancer Res. 2016 May 12;35:78. doi: 10.1186/s13046-016-0356-5.
3
Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.
淋巴瘤中PI3K/Akt/mTOR信号通路抑制剂的研究现状
Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):335-42. doi: 10.1016/j.clml.2014.01.007. Epub 2014 Feb 7.
4
Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases.磷脂酰肌醇-3,4,5-三磷酸:I 类 PI3-激酶的首选工具。
Bioessays. 2013 Jul;35(7):602-11. doi: 10.1002/bies.201200176.
5
Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.核而非胞质磷酸肌醇 3-激酶β在细胞存活中具有重要功能。
Mol Cell Biol. 2011 May;31(10):2122-33. doi: 10.1128/MCB.01313-10. Epub 2011 Mar 7.
6
A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.PI3K p110β催化亚基致癌潜能的生化机制。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19897-902. doi: 10.1073/pnas.1008739107. Epub 2010 Oct 28.
7
Class I PI3K in oncogenic cellular transformation.I类磷脂酰肌醇-3激酶在致癌性细胞转化中的作用
Oncogene. 2008 Sep 18;27(41):5486-96. doi: 10.1038/onc.2008.244.
8
Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.蛋白酶激活受体2和β-抑制蛋白对IA类磷酸肌醇3-激酶催化亚基p110α和β的差异调节
Biochem J. 2007 Dec 1;408(2):221-30. doi: 10.1042/BJ20070483.
9
Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.肺部疾病中的磷脂酰肌醇3激酶信号传导:白细胞及其他方面。
Immunology. 2007 Aug;121(4):448-61. doi: 10.1111/j.1365-2567.2007.02663.x.
10
Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.I类磷酸肌醇3激酶的p110β、γ和δ亚型诱导的致癌转化。
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1289-94. doi: 10.1073/pnas.0510772103. Epub 2006 Jan 23.